Metabolic alteration in oxylipins and endocannabinoids point to an important role for soluble epoxide hydrolase and inflammation in Alzheimer’s disease: finding from Alzheimer’s Disease Neuroimaging Initiative

Author(s):: Borkowski, K.; Yin, C. (0000-0002-4017-9389); Kindt, A.; Liang, N.; Lange, E.C.M. de (0000-0001-8303-1117); Blach, C.; Newman, J.W.; Kaddurah-Daouk, R.; Hankemeier, H.

Published: 2026
Publication type: Article / Letter to editor

Date issued: 2026-01-07
Language: English
Publisher: Springer Science and Business Media LLC
Is part of: Alzheimer’s Research & Therapy (2026), 21
hdl: 1887/4289894
doi: 10.1186/s13195-025-01939-9
URL: https://link.springer.com/article/10.1186/s13195-025-01939-9